Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Depression 3Anxiety Disorders 3Neoplasms 2Ovarian Neoplasms 1Opioid-Related Disorders 1Neoplasm Metastasis 1Depressive Disorder 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Agnosia 1

Interventions

Tirzepatide 1Psilocybin 1Olanzapine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Opioid-Related Disorders × Psilocybin × Clear all
NCT06001749 2025-12-16

Psilocybin in Cancer Pain Study

Dana-Farber Cancer Institute

Phase 2 Recruiting
15 enrolled

Agnosia, Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡